Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Breast 2Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 9Breast Neoplasms 4Papillomavirus Infections 3Prostatic Neoplasms 2Colorectal Neoplasms 2Rectal Neoplasms 1Overweight 1Obesity 1Lung Neoplasms 1Diabetes Mellitus 1Colonic Neoplasms 1

Interventions

pembrolizumab 8Oxaliplatin 7Surveys and Questionnaires 5Methods 5Early Intervention, Educational 5Cyclophosphamide 5Cisplatin 5Paclitaxel 4Magnetic Resonance Spectroscopy 4Leucovorin 4Gemcitabine 4Fluorouracil 4Carboplatin 4veliparib 3aldesleukin 3Trastuzumab 3Specimen Handling 3Nivolumab 3Diathermy 3Cytoreduction Surgical Procedures 3sargramostim 2entinostat 2cemiplimab 2cediranib 2X-Rays 2Therapeutics 2Radiotherapy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Metformin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Patient Navigation × Gynecologic × Clear all
NCT00379743 2018-04-26

Partnership for Healthy Seniors

Johns Hopkins Bloomberg School of Public Health

Phase NA Completed
2,593 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡